SCHEMBL7666144

SCHEMBL7666144

CCCCn1cnc2c(OC)nc(Nc3ccc(OC)c(OC)c3)nc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 2/20 0.45
▸ CCND1 P24385 2/20 0.45
▸ CCND2 P30279 2/20 0.45
▸ CCND3 P30281 2/20 0.45
▸ PDGFRA P16234 8/20 0.44
▸ CCNE1 P24864 8/20 0.44
▸ CDK2 P24941 8/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.41
▸ PSEN1 P49768 1/20 0.40
▸ PSEN2 P49810 1/20 0.40
▸ APH1B Q8WW43 1/20 0.40
▸ NCSTN Q92542 1/20 0.40
▸ APH1A Q96BI3 1/20 0.40
▸ PSENEN Q9NZ42 1/20 0.40
▸ EHMT2 Q96KQ7 1/20 0.39
▸ EHMT1 Q9H9B1 1/20 0.39
▸ CTSL P07711 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7672132 0.91 GALR2 (0.44) PDGFRACCNE1CDK2CTSLMAPT
SCHEMBL7674300 0.86 CTSL (0.50) CDK4CCND1CCND2CCND3PDGFRA
SCHEMBL7358873 0.85 CTSL (0.46) PDGFRACCNE1CDK2CTSLPOLA1
SCHEMBL7661515 0.85 CCNE1 (0.54) CDK4CCND1CCND2CCND3PDGFRA
SCHEMBL7673595 0.84 KDM4E (0.45) PDGFRACCNE1CDK2CTSLMAPT
SCHEMBL7674302 0.83 PDGFRA (0.44) PDGFRACCNE1CDK2CTSLMEN1
SCHEMBL7672897 0.83 LMNA (0.50) PDGFRACCNE1CDK2MAPTMEN1
SCHEMBL7671191 0.83 GBA1 (0.48) PDGFRACCNE1CDK2CTSLMAPT
SCHEMBL7666120 0.82 PDGFRA (0.49) PDGFRACCNE1CDK2CTSLMAPT
SCHEMBL7674135 0.82 PDGFRA (0.43) PDGFRACCNE1CDK2CTSLPOLA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US disclosed
Send feedback